Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is -57.11% as of the fiscal period ended Wednesday, December 31, 2025.
Limited history available
KARD Return on Invested Capital (ROIC) has fewer than three reported periods, so a trend chart would be misleading.
RETURN ON INVESTED CAPITAL (ROIC)
-57.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.91%
median of 678 covered companies
CURRENT VS SECTOR MEDIAN
-68.39%
vs the sector median at left
Kardigan, Inc.
Market Cap
$1.28B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.25B
Return on Invested Capital (ROIC)
-40.32%
TTM Avg
-46.81%
3Y Avg
-44.75%
5Y Avg
-38.73%
Market Cap
$1.32B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-45.26%
3Y Avg
-38.46%
5Y Avg
-34.74%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
1.32%
TTM Avg
13.41%
3Y Avg
0.51%
5Y Avg
-22.96%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
-0.18%
TTM Avg
-25.12%
3Y Avg
-34.79%
5Y Avg
-34.79%
Market Cap
$1.21B
Return on Invested Capital (ROIC)
9.48%
TTM Avg
1.29%
3Y Avg
-3.62%
5Y Avg
0.10%
Market Cap
$1.35B
Return on Invested Capital (ROIC)
-32.06%
TTM Avg
-61.92%
3Y Avg
-50.73%
5Y Avg
-59.82%
Market Cap
$1.18B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kardigan, Inc. (KARD) | $1.28B | -57.11% | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.25B | -40.32% | -46.81% | -44.75% | -38.73% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -40.47% | -45.26% | -38.46% | -34.74% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 1.12% | -4.20% | -6.46% | -10.06% |
| MannKind Corporation (MNKD)vs › | $1.22B | 1.32% | 13.41% | 0.51% | -22.96% |
| Omada Health (OMDA)vs › | $1.23B | -0.18% | -25.12% | -34.79% | -34.79% |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 9.48% | 1.29% | -3.62% | 0.10% |
| Omeros Corporation (OMER)vs › | $1.35B | -32.06% | -61.92% | -50.73% | -59.82% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.18B | -52.44% | -96.82% | -100.85% | -77.97% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.37B | -38.09% | -38.09% | -38.09% | -38.09% |
ROIC
-57.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -57.11% |
